RNA5SP64

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA5SP64 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNA5SP64 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNA5SP64 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP64 expression acts as an unfavorable survival marker.

SKCM, BRCA, and BLCA are the cancer types where RNA5SP64 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMOSTertileII,III,IV0.4120.744<.00184view →
BRCADFSTertileII,III,IV0.7850.943.00272view →
BLCADFSTertileAll0.0150.594<.00118view →
LGGOSTertileAll0.5530.891.0089view →
PRADOSTertileAll0.4910.893.0036view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNA5SP64–SKCM (OS)

Kaplan–Meier survival curve for RNA5SP64 RNA-high vs -low samples in SKCM.

Open the SKCM breakdown →

Exploration